Ahmet Sami Bosnak

Dr. Ahmet Sami Bosnak


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2018 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
NBNEVZAT BİRAND
NEVZAT BİRAND
ÖDÖmer Diker
Ömer Diker
AAAbdikarim Abdi
Abdikarim Abdi
BBBilgen Başgut
Bilgen Başgut
Background: Clinical pharmacists have important roles in implementing scientifically valid knowledge and advice on safe, reasonable use of pharmaceuticals. Clinical pharmacy services were introduced and evaluated in oncology clinic in a tertiary university hospital. Methods: A prospective interventional study was conducted from November 2017 to March 2018. Drug-related problems were classified using the Pharmaceutical Care Network Europe drug-related problem classification tool v8.01. The main outcome measure is the proposed interventions aimed at identification of the drug-related problems, the role of the pharmacists in the resolution, and the rate of acceptance of these recommendations by physicians. Results: A total of 102 patients were included in the study, who were treated with at least two cycles of any cancer type and stage. A total of 55 (53.9%) patients had 251 drug-related problems. Drug-related problems mainly involved antihypertensive (31.6%), antidiabetic (17.8%), and herbal agents (31.6%). Treatment effectiveness was the major type of drug-related problems (50.2%) followed by treatment safety (29.1%). A total of 211 (100%) interventions were accepted and regarded as clinically relevant. Prescriber informed only were the most common types of intervention at the prescriber level. Eighty-six point four percent identified drug-related problems were solved, 9.8% of the problems were partially solved, 2.3% problems were unsolved. Conclusion: Clinical pharmacy services may have optimized therapy effectiveness, prevent adverse effects and unclear/compliant problems. The pharmacist interventions were highly acknowledged by oncologists and patients; this may indicate the presence of a great convenience and need to implement Clinical pharmacy services in alternative hospitals in Northern Cyprus.

20 February 2019 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
NBNEVZAT BİRAND
NEVZAT BİRAND
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
ÖDÖmer Diker
Ömer Diker
AAAbdikarim Abdi
Abdikarim Abdi
BBBilgen Başgut
Bilgen Başgut
Background: Multiple factors have been reported to affect adherence to medication, including beliefs about medicines, while specifically tailored pharmaceutical care services for patients may improve adherence. The aim was to assess the impact of counselling by an oncology pharmacist on patients' medication adherence and beliefs. Methods: An interventional prospective study was performed in the oncology department at a tertiary hospital in Northern Cyprus from November 2017 to April 2018. The Beliefs about Medicines Questionnaire was used to evaluate the balance between beliefs about necessity and concerns and medication beliefs before and after an educational intervention. The Morisky Green Levine Test 2018 was used to evaluate adherence. Results: In total, 81 patients (65.4% females; mean age: 59.1 ± 11.34 years; 34.6% hypertensive; 19.8% with diabetes) were analysed before and after receiving counselling from an oncology pharmacist. Pharmacist education significantly enhanced the mean patient necessity-concern balance scores by two-fold (MT0(baseline) = −3.1 ± 8.6; MT1(posteducation) =3.0 ± 7.3; p < 0.0001), with patients who received counselling for the first time experiencing the greatest benefit. Multivariate analysis showed that patients who had a negative balance between their beliefs about the necessity of the medication and their concerns were less likely to adhere to the medication (0.138 (0.025–0.772)). Conclusion: Counselling by an oncology pharmacist was effective in decreasing patient concerns and increasing their understanding of the necessity of the medication, thus enhancing their adherence and consequently improving the care they received.

1 July 2019 in European Journal of Oncology Pharmacy
Verified
Journal Article
Open access
KMKlaus Meier
Klaus Meier
AAAlain Astier
Alain Astier
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
RGRoman Goněc
Roman Goněc
The way we treat cancer is changing. Scientific and technological advances such as tumour profiling, ‘big data,’ and an increasing number of targeted therapies and combination regimens will result in a paradigm shift away from a ‘one-size-fits-all’ concept toward personalized, on-demand, precision medicine, which will result in smaller, more defined patient populations. In parallel, the global incidence of cancer is rising, which is placing an increasing strain on medical oncology centres, and driving the evolution of oncology pharmacy. Clinical pharmacists can reduce the pressures on other healthcare resources by taking an increased role in patient care and providing a broader range of services. Pharmacists recognize that technological developments will lead to significant changes in pharmacy services, which will require greater integration with other services within the healthcare system. Members of the European Society of Oncology Pharmacy (ESOP) met at the 4th European Conference of Oncology Pharmacy (ECOP) meeting in October 2018 for a symposium entitled The Future of Oncology Pharmacy 2025. This review summarizes several topics discussed at the meeting, including the future of medicine, oncology and pharmacy healthcare, provides an update on ESOP activities and presents the ECOP 2018 resolution. This position statement outlines the ESOP perspective on how oncology pharmacy will change over the next decade, and how it will respond to these changes to support oncology pharmacists and achieve better outcomes for patients with cancer.

15 April 2025 in Cyprus Journal of Medical Sciences
Verified
Journal Article
Open access
NBNevzat Birand
Nevzat Birand
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
AMArmin Moshfeghifar
Armin Moshfeghifar
Assessment of Herbal Interactions with Anti-Cancer Drugs Using Two Drug Interaction Checker Databases and Attitudes of Cancer Patients Toward the Use of Herbal Products/Medicines: Single Center Experience - Cyprus Journal of Medical Sciences

28 April 2022 in Konuralp Tip Dergisi
Verified
Journal Article
Closed access
GAGloria Nnadwa Alhassan
Gloria Nnadwa Alhassan
FAFelicia Bodi Alhassan
Felicia Bodi Alhassan
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
In the context of COVID-19 in North Central Nigeria, a qualitative interview study was conducted to assess the impact on the maintenance of essential sexual, reproductive, maternal newborn, child, adolescent healthy plus nutrition serves (RMNCAH+N). This proposition aligns with the global crusade of the United Nations Sustainable development goals (UNSDGs 2.3.8) that highlights good nutrition (zero hunger) access to quality healthy and sustainable economic growth path. To this end, a field survey design was done qualitatively. Key informant interviews (KIIs) and focus group discussions (FGDs) were used in the qualitative analysis, which was based on typical interview schedules. Key study finding outlines that healthcare workers reported a variety of tough emotions and psychological issues, this included insufficient medical equipment’s, dissatisfaction with members of the public who did not observe social distancing norms, concerns about protecting their loved ones from infection, increased workload, and changing working conditions, insufficient personal protective equipment kits (PPE), and a sense that their frontline work was being undermined also a significant increase in gender-based violence. Further policy suggestions are outlined in the concluding section.

28 April 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
MAMohammad Ali Al-qarni
Mohammad Ali Al-qarni
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
ETEsra Taybeh
Esra Taybeh
Background: Treatment-related problems (TRPs), including patient adherence, knowledge, and medication errors, affect hospitalized patients’ outcomes worldwide. Effective clinical pharmacist communication is essential for proper patient counselling and medication safety. However, the effect of clinical pharmacist communication skills on TRPs has not been adequately studied. Objective: This study aimed to assess patients’ satisfaction with clinical pharmacists’ communication components (appropriate timing, language, and empathy) and examine their association with TRPs, including patient adherence, knowledge, and medication errors. Method: A cross-sectional study was conducted in two Jordanian public hospitals between October 2023 and April 2024 through a structured questionnaire to assess patients’ satisfaction, adherence, and knowledge. Medication errors were detected in collaboration with other healthcare providers through reviewing medical records and direct patient assessment based on the American Society of Health-System Pharmacists classification. Data analysis was conducted using SPSS version 27. Results: A total of 613 adult inpatients were included. Overall, 82.1% (n = 503) of patients were satisfied with the clinical pharmacist communication, 75.5% (n = 463) showed good adherence, and 76% (n = 466) showed good knowledge. A total of 42.4% of medication errors (n = 260) were identified. Errors with harm or fatalities were not observed. The regression results showed that the overall satisfaction level was positively associated with patients’ adherence rate (B = 0.59; p < 0.001) and patients’ knowledge (B = 0.978; p < 0.001) and negatively associated with the number of medication errors (B = −0.024; p < 0.001). Conclusions: Clear, timely, and empathetic communication by clinical pharmacists was associated with patient satisfaction and was linked to better patient adherence and knowledge and fewer medication errors. Improving communication skills among clinical pharmacists could be a practical way to reduce TRPs.